CLINICAL AND PRECLINICAL ACTIVITY OF 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE)

被引：133
作者：
LUND, B
KRISTJANSEN, PEG
HANSEN, HH
机构：
[1] Department of Oncology 5072, Rigshospitalet, DK-2100 Copenhagen
来源：
CANCER TREATMENT REVIEWS | 1993年 / 19卷 / 01期
关键词：
D O I：
10.1016/0305-7372(93)90026-N
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：45 / 55
页数：11
相关论文
共 34 条
[1]  
ABBRUZZESE J, 1991, P AN M AM SOC CLIN, V10, P147
[2]   A PHASE-I CLINICAL, PLASMA, AND CELLULAR PHARMACOLOGY STUDY OF GEMCITABINE [J].
ABBRUZZESE, JL ;
GRUNEWALD, R ;
WEEKS, EA ;
GRAVEL, D ;
ADAMS, T ;
NOWAK, B ;
MINEISHI, S ;
TARASSOFF, P ;
SATTERLEE, W ;
RABER, MN ;
PLUNKETT, W .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (03) :491-498
[3]  
ABRATT R, 1992, P AN M AM SOC CLIN, V11, P311
[4]   COMPARISON OF ANTINEOPLASTIC ACTIVITY OF 2',2'-DIFLUORODEOXYCYTIDINE AND CYTOSINE-ARABINOSIDE AGAINST HUMAN MYELOID AND LYMPHOID LEUKEMIC-CELLS [J].
BOUFFARD, DY ;
MOMPARLER, LF ;
MOMPARLER, RL .
ANTI-CANCER DRUGS, 1991, 2 (01) :49-55
[5]  
BRAKHUIS BJM, 1991, CANCER RES, V51, P211
[6]  
BROWN T, 1991, P AN M AM SOC CLIN, V10, P115
[7]  
CARMICHAEL J, 1992, P AN M AM SOC CLIN, V11, P77
[8]  
CASPER ES, 1991, P AN M AM SOC CLIN, V10, P143
[9]  
CLAVEL M, 1992, P AN M AM SOC CLIN, V11, P249
[10]  
Delong D. C., 1986, AM SOC MICR ABSTR
1234